 Ondansetron new entity emesis control Nausea vomiting serious problems patients cancer chemotherapy Dopamine receptor cholinergic receptor antagonism target mechanism agents drug-induced nausea vomiting blockade serotonin receptors indication Current therapies extrapyramidal adverse effects drowsiness sedation respiratory depression cardiac effects Ondansetron investigational serotonin antagonist effectiveness cancer chemotherapy-induced emesis Ondansetron possible exception headaches transient increases liver enzymes extrapyramidal toxicities agent ondansetron looks studies role antiemetic